P Kellie Turner

3PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 27, 2026
Longitudinal Tumor Size and Survival Modeling for Exposure-Response Analysis of Drugs with Frequent Dose Reductions: Dose Justification of Abemaciclib in Patients with Metastatic Breast Cancer.

Emmanuel Chigutsa, Sonya C Chapman, P Kellie Turner

|Jun 20, 2023
Abemaciclib does not increase the corrected QT interval in healthy participants.

Jill C Chappell, Alan Y Chiang, Jane Royalty

|Jun 26, 2020
Abemaciclib Does Not Have a Clinically Meaningful Effect on Pharmacokinetics of CYP1A2, CYP2C9, CYP2D6, and CYP3A4 Substrates in Patients with Cancer.

P Kellie Turner, Stephen D Hall, Sonya C Chapman

Pageof 1

Frequent Collaborators

1 joint publications

Sonya C Chapman